MedPath

Hypromellose

Generic Name
Hypromellose
Brand Names
Bion Tears, Clear Eyes Complete, Genteal, Genteal Tears, Genteal Tears Mild, Gonak, Goniovisc, Isopto Alkaline, Nature's Tears, Systane, Tears Lubricant, Tears Naturale, Tears Renewed
Drug Type
Small Molecule
CAS Number
9004-65-3
Unique Ingredient Identifier
3NXW29V3WO

Overview

Hypromellose, or hydroxypropyl methylcellulose (HPMC) , is a semisynthetic, inert, and viscoelastic polymer that forms a colloid solution when dissolved in water. It acts as a thickening agent, coating polymer, bioadhesive, solubility enhancer in solid dispersions, and binder in the process of granulation and in modified release formulations . It is a commonly used as a delivery component in oral pharmaceutical products that provides the release of a drug in a controlled fashion, effectively increasing the duration of release of a drug to prolong its therapeutic effects . Hypromellose is also found in eye drops as a lubricant .

Indication

Used as an ophthalmic protectant and lubricant, in artificial tears, and as a diagnostic aid (contact lens procedures; gonioscopy).

Associated Conditions

  • Dry Eyes
  • Ocular Discomfort
  • Ocular Irritation

Research Report

Published: Aug 18, 2025

A Comprehensive Monograph on Hypromellose (DB11075): Physicochemical Properties, Pharmaceutical Applications, and Safety Profile

1.0 Executive Summary

Hypromellose, also known by its chemical name hydroxypropyl methylcellulose (HPMC), is a semisynthetic, inert, viscoelastic polymer derived from cellulose. It stands as a cornerstone of modern pharmaceutical science due to its remarkable versatility, functioning as both a primary therapeutic agent in ophthalmic formulations and an indispensable excipient in a vast array of oral and topical drug delivery systems.[1] This monograph provides a comprehensive analysis of Hypromellose, integrating its physicochemical characteristics, pharmacological mechanisms, pharmacokinetic profile, clinical applications, and safety data. The fundamental utility of Hypromellose is rooted in a predictable structure-function paradigm, where its molecular properties—specifically the degree of chemical substitution and polymer chain length—can be precisely modulated to control macroscopic behaviors such as viscosity, hydration rate, and thermal gelation. This tunability allows for the engineering of specific performance outcomes, from providing gentle, long-lasting lubrication for the ocular surface to orchestrating the complex, zero-order release of active pharmaceutical ingredients from once-daily oral tablets.

Continue reading the full research report

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
2025/07/03
Not Applicable
Not yet recruiting
Center for Sight Las Vegas
2025/03/20
Phase 4
Recruiting
2025/01/08
Phase 4
Recruiting
2024/04/23
Phase 1
Not yet recruiting
2024/01/24
Phase 4
Completed
Chang Gung Memorial Hospital
2024/01/23
Phase 4
Completed
Scripps Poway Eyecare and Optometry
2024/01/03
Phase 2
Completed
2023/01/30
Phase 4
Completed
2022/10/26
Phase 4
Completed
Tauber Eye Center
2021/04/30
Not Applicable
Completed

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
LOSTEAR EYE DROPS 0.3% W/V
N/A
N/A
N/A
7/6/2016
GENTEAL EYE GEL
N/A
alcon hong kong ltd
N/A
N/A
2/16/2004

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
MediHerb Gotu Kola Complex (Export Only)
389071
Medicine
A
5/25/2022

Health Canada Drug Approvals

Approved Product
Company
DIN
Dosage Form
Strength
Market Date
ARTELAC LUBRICANT EYE DROPS
bausch & lomb inc
02251523
Solution - Ophthalmic
0.32 %
3/25/2005
VISINE CONTACT LENS
johnson & johnson inc
02229483
Drops - Ophthalmic
0.2 %
8/24/1998
LUBRICANT EYE DROPS
kc pharmaceuticals inc
02455579
Solution - Ophthalmic
0.2 % / W/V
N/A
DRY EYE TEARS
juno otc inc
02389886
Solution - Ophthalmic
0.2 % / W/V
2/12/2014
ALCON TEARS 1%
Alcon Canada Inc
00000817
Solution - Ophthalmic
1 % / W/V
12/31/1970
TEARS NATURALE
Alcon Canada Inc
00390291
Solution - Ophthalmic
0.3 %
12/31/1977
TEARS NATURALE FORTE
Alcon Canada Inc
02246397
Solution - Ophthalmic
0.3 %
1/2/2003
VISINE FOR DRY EYE EYE REVIVAL
johnson & johnson inc
02436132
Drops - Ophthalmic
0.2 % / W/V
5/19/2016
ARTIFICIAL TEARS
juno otc inc
02354535
Solution - Ophthalmic
0.2 % / W/V
4/19/2011
CORNEO HYPROMELLOSE
orimed pharma inc
02439921
Solution - Ophthalmic
0.3 %
9/16/2015

CIMA AEMPS Drug Approvals

Approved Product
Company
Registration Number
Pharmaceutical Form
Prescription Type
Status
HIPROMELOSA LESVI 3,2 MG/ML COLIRIO EN SOLUCION EN ENVASE UNIDOSIS
Laboratorios Lesvi Sl
78526
COLIRIO EN SOLUCIÓN EN ENVASE UNIDOSIS
Sin Receta
Not Commercialized
ACUOLENS 3 mg/ml + 5,5 mg/ml COLIRIO EN SOLUCION EN ENVASE UNIDOSIS
Alcon Healthcare S.A.
62630
COLIRIO EN SOLUCIÓN
Sin Receta
Commercialized
HIPROMELOSA STADA 3,2 MG/ML COLIRIO EN SOLUCION EN ENVASE UNIDOSIS
Laboratorio Stada S.L.
78527
COLIRIO EN SOLUCIÓN EN ENVASE UNIDOSIS
Sin Receta
Commercialized
ARTIFIC 3,20 MG/ML COLIRIO EN SOLUCION
14328
COLIRIO EN SOLUCIÓN
Sin Receta
Not Commercialized
ARTIFIC 3,20 mg/ml COLIRIO EN SOLUCION EN ENVASE UNIDOSIS
Bausch & Lomb S.A.
65809
COLIRIO EN SOLUCIÓN
Sin Receta
Commercialized
DACROLUX 3MG/ML +1MG/ML COLIRIO EN SOLUCIÓN
Reva Health Europe S.L.
58742
COLIRIO EN SOLUCIÓN
Sin Receta
Not Commercialized
ARTIFIC 3,20 mg/ml COLIRIO EN SOLUCION EN ENVASE UNIDOSIS
3400934035890
COLIRIO EN SOLUCIÓN
Sin Receta
Commercialized
ARTIFIC 3,20 MG/ML COLIRIO EN SOLUCION EN ENVASE UNIDOSIS
14329
COLIRIO EN SOLUCIÓN EN ENVASE UNIDOSIS
Sin Receta
Not Commercialized
HIPROMELOSA QUALIGEN 3,2 MG/ML COLIRIO EN SOLUCION EN ENVASE UNIDOSIS
Neuraxpharm Spain S.L.
78532
COLIRIO EN SOLUCIÓN EN ENVASE UNIDOSIS
Sin Receta
Not Commercialized
ARTIFIC 3,20 mg/ml COLIRIO EN SOLUCION
Bausch & Lomb S.A.
65810
COLIRIO EN SOLUCIÓN
Sin Receta
Commercialized

Philippines FDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

Approved Product
Company
Registration Number
Dosage Form
Strength
Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

Medicine Name
MA Holder
MA Number
Pharmaceutical Form
Active Ingredient
Authorization Date
No UK EMC drug information found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.